Structure Therapeutics, Inc. (GPCR)
43.23
+1.70
(+4.09%)
USD |
NASDAQ |
Jun 11, 16:00
43.23
0.00 (0.00%)
After-Hours: 18:14
Structure Therapeutics Total Liabilities (Quarterly) : 61.03M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 61.03M |
| December 31, 2025 | 67.54M |
| September 30, 2025 | 62.14M |
| June 30, 2025 | 44.36M |
| March 31, 2025 | 41.91M |
| December 31, 2024 | 38.49M |
| September 30, 2024 | 36.42M |
| June 30, 2024 | 26.00M |
| March 31, 2024 | 27.41M |
| Date | Value |
|---|---|
| December 31, 2023 | 29.05M |
| September 30, 2023 | 23.41M |
| June 30, 2023 | 15.01M |
| March 31, 2023 | 11.00M |
| December 31, 2022 | 13.01M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 8.930M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.38B |
| Novo Nordisk A/S | 54.92B |
| Viking Therapeutics, Inc. | 106.32M |
| Pfizer Inc. | 117.21B |
| Tarsus Pharmaceuticals, Inc. | 232.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.508B |
| Shareholders Equity (Quarterly) | 1.447B |
| Debt to Equity Ratio | 0.004 |
| Current Ratio | 26.16 |
| Net Debt Paydown Yield | -0.01% |